Analyze Diet

Topic:Dopamine

Dopamine is a neurotransmitter present in the central nervous system of horses, involved in regulating various physiological and behavioral processes. It plays a role in movement, mood, and reward mechanisms, influencing how horses respond to stimuli and interact with their environment. Dopamine pathways in horses are similar to those in other mammals and are integral to neural communication and function. Research on dopamine in horses explores its effects on behavior, training responses, and its potential involvement in neurological disorders. This page compiles peer-reviewed research studies and scholarly articles that examine the role, regulation, and implications of dopamine in equine neurobiology and behavior.
Evidence for dopamine production and distribution of dopamine D2 receptors in the equine gastrointestinal mucosa and pancreas.
PloS one    February 27, 2024   Volume 19, Issue 2 e0298660 doi: 10.1371/journal.pone.0298660
Galinelli NC, Bamford NJ, de Laat MA, Sillence MN, Harris PA, Bailey SR.Insulin dysregulation in horses is characterised by hyperinsulinaemia and/or tissue insulin resistance and is associated with increased risk of laminitis. There is growing evidence in other species that dopamine attenuates insulin release from the pancreas; however, this has yet to be examined in horses. The present study aimed to identify whether there are cells capable of producing or responding to dopamine within the equine gastrointestinal mucosa and pancreas. Tissue samples were collected from the stomach, small and large intestines, and pancreas of six mature horses following euthanasia....
Relationship between plasma dopamine concentration and temperament in horses.
Domestic animal endocrinology    March 24, 2023   Volume 83 106788 doi: 10.1016/j.domaniend.2023.106788
Kim J, Jung H, Yoon M.Dopamine (DA) is a neurotransmitter associated with animal behaviors. Along with other neurotransmitters such as oxytocin (OXT) and serotonin (5-HT), DA is also involved in determining the temperament of animals. However, the involvement of DA in horse temperament has not been well elucidated. Therefore, in this study, we aimed to determine the correlation between plasma DA concentration and OXT and 5-HT concentrations and behavioral temperament (eg, docility and friendliness, fearfulness, dominance, and trainability) of horses. Blood samples were collected from 31 horses and the concentration...
3-Methoxytyrosine as an indicator of dopaminergic manipulation in equine plasma.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences    March 7, 2023   Volume 1220 123652 doi: 10.1016/j.jchromb.2023.123652
Keen B, Cawley A, Reedy B, Noble G, Loy J, Fu S.The use of catechol-O-methyltransferase inhibitors may mask doping agents, primarily levodopa, administered to racehorses and prolong the stimulating effects of dopaminergic compounds such as dopamine. It is known that 3-methoxytyramine is a metabolite of dopamine and 3-methoxytyrosine is a metabolite of levodopa thus these compounds are proposed to be potential biomarkers of interest. Previous research established a urinary threshold of 4,000 ng/mL for 3-methoxytyramine to monitor misuse of dopaminergic agents. However, there is no equivalent biomarker in plasma. To address this deficiency a...
Correlation of pituitary histomorphometry with dopamine and dopamine D2 receptor expression in horses with pituitary pars intermedia dysfunction.
Research in veterinary science    August 24, 2022   Volume 152 427-433 doi: 10.1016/j.rvsc.2022.08.018
Huang L, Palmieri C, Bertin FR.Pituitary pars intermedia dysfunction (PPID) is an endocrinopathy commonly affecting old horses. It is a spontaneously occurring, progressive disease that is still poorly understood. Previous studies have observed neurodegeneration of the dopaminergic inhibition of melanotrophs, which leads to decreased dopamine (DA) in the pars intermedia (PI) and increased pro-opiomelanocortin-derived peptides circulating in plasma. However, rats knockout for the dopamine D2 receptor (D2r) similarly develop PI hypertrophy and hyperplasia. Thus, based on the current pathophysiological theory of PPID, whether ...
Plasma concentration of dopamine varies depending on breed, sex, and the genotype of DRD4 in horses.
Journal of animal science and technology    July 31, 2022   Volume 64, Issue 4 792-799 doi: 10.5187/jast.2022.e44
Kim J, Jung H, Choi JY, Lee JW, Yoon M.Dopamine (DA) is known to be a key modulator of animal behaviors. Thus, the plasma concentration of DA might be used as a biomarker for the behavioral characteristics of horses. The behavioral characteristics of horses vary depending on the breed, age, and sex. Moreover, the DA receptor genotypes are also related to horse behaviors. Thus, the aim of this study was to investigate the DA concentration variations of horse plasma by breed, age, sex, or genotype of its receptor. The horses were divided by breed into Thoroughbred (n = 13), Pony (n = 9), Warmblood (n = 4), and Haflinger (n = 5). The ...
The impulsive horse: Comparing genetic, physiological and behavioral indicators to those of human addiction.
Physiology & behavior    June 28, 2022   Volume 254 113896 doi: 10.1016/j.physbeh.2022.113896
McBride SD, Roberts K, Hemmings AJ, Ninomiya S, Parker MO.Stress and genotype elicit changes in impulse control in a range of species that are attributable to adaptations in both the central and peripheral nervous system. We examined aspects of this mechanism in the horse by assessing the effect of a dopamine receptor genotype (DRD4) and central dopaminergic tone (measured via spontaneous blink rate [SBR] and behavioral initiation rate [BIR]), on measures of impulsivity, compulsivity (3-choice serial reaction time task) and sympathetic/ parasympathetic system balance (heart rate variability [HRV]). Genotype did not have a significant effect on any of...
Preliminary study on the effects of pergolide on left ventricular function in the horses with pituitary pars intermedia dysfunction.
Journal of veterinary science    September 24, 2021   Volume 22, Issue 5 e64 doi: 10.4142/jvs.2021.22.e64
Gehlen H, Fisch J, Merle R, Trachsel DS.Pituitary pars intermedia dysfunction (PPID), a neurodegenerative disease leading to reduced dopamine production, is a common disease in aged horses. The treatment is based on administration of the dopamine agonist pergolide. This drug has been related to valvular fibrosis in humans, but the cardiovascular effect of this drug has not yet been investigated in horses. Objective: To determine whether pergolide induces valvular disease in horses or affects the cardiac function. Methods: Standard, tissue Doppler (TDE) and two-dimensional speckle tracking (STE) echocardiography were performed in hor...
Astrocyte inflammatory signaling mediates α-synuclein aggregation and dopaminergic neuronal loss following viral encephalitis.
Experimental neurology    August 26, 2021   Volume 346 113845 doi: 10.1016/j.expneurol.2021.113845
Bantle CM, Rocha SM, French CT, Phillips AT, Tran K, Olson KE, Bass TA, Aboellail T, Smeyne RJ, Tjalkens RB.Viral infection of the central nervous system (CNS) can cause lasting neurological decline in surviving patients and can present with symptoms resembling Parkinson's disease (PD). The mechanisms underlying postencephalitic parkinsonism remain unclear but are thought to involve increased innate inflammatory signaling in glial cells, resulting in persistent neuroinflammation. We therefore studied the role of glial cells in regulating neuropathology in postencephalitic parkinsonism by studying the involvement of astrocytes in loss of dopaminergic neurons and aggregation of α-synuclein protein fo...
Short-term infusion of ultralow-dose dopamine in an adult horse with acute kidney injury: A case report.
Veterinary and animal science    April 11, 2021   Volume 12 100176 doi: 10.1016/j.vas.2021.100176
Matsuda H, Matsuda K, Muko R, Oikawa MA, Tanaka A.Much is known regarding a good prognosis of acute kidney injury (AKI) is achieved with adequate, intensive, and early treatment, which leads to acceleration of the renal blood flow rate and associated urination. Low-dose dopamine (1 to 5 μg/kg bwt per min) is a treatment option for AKI in humans but remains controversial for use in horses because of the lack of extensive clinical trial data. A 19-year-old Westfalen horse gelding was referred to the Animal Medical Center with a 1-hour history of mild abdominal pain and anorexia after dressage exercise for 1 hour. Since elevated serum levels o...
Peripheral Modulators of the Central Fatigue Development and Their Relationship with Athletic Performance in Jumper Horses.
Animals : an open access journal from MDPI    March 8, 2021   Volume 11, Issue 3 743 doi: 10.3390/ani11030743
Arfuso F, Giannetto C, Giudice E, Fazio F, Panzera M, Piccione G.The current study aimed to investigate whether peripheral modulators of serotoninergic function and neurohumoral factors' changes in athletic horses during an official jumping competition, and to evaluate their relationship with the physical performance of competing horses. From 7 Italian Saddle mares (6-9 years; mean body weight 440 ± 15 kg), performing the same standardized warm-up and jumping course during an official class, heart rate (HR) was monitored throughout the competition. Rectal temperature (RT) measurement, blood lactate and glucose concentration, serum tryptophan, leucine, vali...
Markers of muscle atrophy and impact of treatment with pergolide in horses with pituitary pars intermedia dysfunction and muscle atrophy.
Domestic animal endocrinology    February 18, 2021   Volume 76 106620 doi: 10.1016/j.domaniend.2021.106620
Banse HE, Whitehead AE, McFarlane D, Chelikani PK.Pituitary pars intermedia dysfunction (PPID) is a common endocrine disorder of aged horses, with muscle atrophy as one of the clinical signs. We sought to compare muscle mass and regulation of skeletal muscle proteolysis between horses with PPID and muscle atrophy to older horses without PPID, and to assess the impact of treatment with pergolide (dopaminergic agonist) on PPID horses. We hypothesized that PPID-associated muscle atrophy is a result of increased proteolysis, and that markers of muscle atrophy and proteolysis would improve over time with pergolide treatment. Markers of muscle atro...
Efficacy of pergolide for the management of equine pituitary pars intermedia dysfunction: A systematic review.
Veterinary journal (London, England : 1997)    October 8, 2020   Volume 266 105562 doi: 10.1016/j.tvjl.2020.105562
Tatum RC, McGowan CM, Ireland JL.Pergolide, a dopamine agonist, is commonly administered to manage pituitary pars intermedia dysfunction (PPID), a progressive neurodegenerative disease prevalent in aged horses. However, available evidence regarding pergolide's efficacy in improving clinical and endocrine parameters is limited. The aim of this systematic review was to assess published literature and evaluate evidence regarding whether pergolide treatment results in improvement of clinical signs and/or adrenocorticotrophic hormone (ACTH) concentration compared to no treatment or other unlicensed treatments. Systematic searches ...
Restoring pars intermedia dopamine concentrations and tyrosine hydroxylase expression levels with pergolide: evidence from horses with pituitary pars intermedia dysfunction.
BMC veterinary research    September 25, 2020   Volume 16, Issue 1 356 doi: 10.1186/s12917-020-02565-3
Fortin JS, Benskey MJ, Lookingland KJ, Patterson JS, Howey EB, Goudreau JL, Schott HC.Pituitary pars intermedia dysfunction (PPID) develops slowly in aged horses as degeneration of hypothalamic dopaminergic neurons leads to proliferation of pars intermedia (PI) melanotropes through hyperplasia and adenoma formation. Dopamine (DA) concentrations and tyrosine hydroxylase (TH) immunoreactivity are markedly reduced in PI tissue of PPID-affected equids and treatment with the DA receptor agonist pergolide results in notable clinical improvement. Thus, we hypothesized that pergolide treatment of PPID-affected horses would result in greater DA and TH levels in PI tissue collected from ...
Accidental Overdose of Pergolide (Prascend) Followed by Loss of Appetite, Tachycardia, and Behavioral Abnormalities in a Pony Mare.
Journal of equine veterinary science    July 8, 2020   Volume 92 103181 doi: 10.1016/j.jevs.2020.103181
Schwarz B, Ihry P.A 26-year-old pony mare (ca. 180 kg bodyweight) was presented as an emergency because it had erroneously received 110 times its standard dose of pergolide (Prascend) per os approximately 4 hours earlier. Clinical examination initially was normal except tachycardia of 52 beats/min. The pony was treated symptomatically with paraffin oil and activated charcoal per nasogastric tube to prevent further systemic absorption and accelerate intestinal excretion of the pergolide. Furthermore, the pony received 400 mg of dopamine antagonist azaperone (Stresnil) intramuscularly (i.m.) followed by 80 mg...
Elevated Sensitivity to Tactile Stimuli in Stereotypic Horses.
Frontiers in veterinary science    May 31, 2019   Volume 6 162 doi: 10.3389/fvets.2019.00162
Briefer Freymond S, Bardou D, Beuret S, Bachmann I, Zuberbühler K, Briefer EF.Although stereotypic behaviors are a common problem in captive animals, why certain individuals are more prone to develop them remains elusive. In horses, individuals show considerable differences in how they perceive and react to external events, suggesting that this may partially account for the emergence of stereotypies in this species. In this study, we focused on crib-biting, the most common stereotypy displayed by horses. We compared how established crib-biters ("CB" = 19) and normal controls ("C" = 18) differed in response to a standard "personality" assessment test battery, i.e., react...
High-throughput screen of drug repurposing library identifies inhibitors of Sarcocystis neurona growth.
International journal for parasitology. Drugs and drug resistance    February 16, 2018   Volume 8, Issue 1 137-144 doi: 10.1016/j.ijpddr.2018.02.002
Bowden GD, Land KM, O'Connor RM, Fritz HM.The apicomplexan parasite Sarcocystis neurona is the primary etiologic agent of equine protozoal myeloencephalitis (EPM), a serious neurologic disease of horses. Many horses in the U.S. are at risk of developing EPM; approximately 50% of all horses in the U.S. have been exposed to S. neurona and treatments for EPM are 60-70% effective. Advancement of treatment requires new technology to identify new drugs for EPM. To address this critical need, we developed, validated, and implemented a high-throughput screen to test 725 FDA-approved compounds from the NIH clinical collections library for anti...
Survey on basal blood plasma catecholamine concentrations in Martina Franca donkey (Equus asinus).
Equine veterinary journal    January 10, 2018   Volume 50, Issue 4 493-497 doi: 10.1111/evj.12799
Catecholamines are among the most frequently investigated parameters for studying sympathoadrenal activity in response to stress conditions. Objective: To evaluate basal plasma concentrations of catecholamines (adrenaline, noradrenaline and dopamine) in healthy donkeys. Methods: Cross-sectional study. Methods: Catecholamine concentrations from 440 Martina Franca donkeys were determined: 269 females and 171 entire males, aged from 4 months to 24 years. Animals were subdivided into four age categories: under 12 months old (64 males and 54 females), from 13 to 36 months (56 males and 75 females),...
Effect of transportation on the sympatho-adrenal system responses in horses.
Research in veterinary science    October 25, 2017   Volume 125 401-404 doi: 10.1016/j.rvsc.2017.10.001
Medica P, Bruschetta G, Cravana C, Ferlazzo A, Fazio E.The objective of current study was to evaluate the effect of transportation stress on the circulating adrenaline (A), noradrenaline (NA) and dopamine (DA) responses of stallions, according to the different distances. Forty-two stallions were studied before and after road transportation of 100, 200 and 300km, for a period of 1-3h. An increase in plasma A after 100km (P<0.001) was observed. A similar result was seen in plasma NA after 100km (P<0.001), and 300km (P<0.001). Increases in plasma DA after 100 and 200km (P<0.0001) were observed, with a decrease after 300km (P<0.0001). S...
Influence of catecholamines at different dosages on the function of the LiDCO sensor in isoflurane anesthetized horses.
Journal of veterinary emergency and critical care (San Antonio, Tex. : 2001)    October 24, 2017   Volume 27, Issue 6 651-657 doi: 10.1111/vec.12672
Hopster K, Ambrisko TD, Kästner SBR.To compare the lithium dilution method for cardiac output (LiDCO) and bolus-thermo-dilution (BTD) measurements before and during infusion of dobutamine, dopamine, phenylephrine, or noradrenaline at 2 different doses in anesthetized horses and to examine the correlation between sensor voltages (saline-blood exposed) and possible measurement errors. Methods: Prospective experimental study. Methods: University teaching hospital. Methods: Nine Warmblood horses. Methods: Following 90 minutes of equilibration, 3 different doses of dobutamine (0.5-3 μg/kg/min), dopamine (1-5 μg/kg/min), phenylephri...
A novel surface plasmon resonance biosensor based on the PDA-AgNPs-PDA-Au film sensing platform for horse IgG detection.
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy    October 12, 2017   Volume 191 290-295 doi: 10.1016/j.saa.2017.10.039
Wang N, Zhang D, Deng X, Sun Y, Wang X, Ma P, Song D.Herein we report a novel polydopamine-silver nanoparticle-polydopamine-gold (PDA-AgNPs-PDA-Au) film based surface plasmon resonance (SPR) biosensor for horse IgG detection. The PDA-AgNPs-PDA-Au film sensing platform was built on Au-film via layer-by-layer self-assembly. Ag ion was reduced in situ to AgNPs in presence of PDA. The top PDA layer can prevent AgNPs from being oxidized and connect with antibody via Schiff alkali reaction directly. The morphology and thickness of the modified gold film were characterized using scanning electron microscope and Talystep. Experimental results show that ...
Effects of dobutamine, dopamine, phenylephrine and noradrenaline on systemic haemodynamics and intestinal perfusion in isoflurane anaesthetised horses.
Equine veterinary journal    August 30, 2017   Volume 50, Issue 1 104-110 doi: 10.1111/evj.12721
Dancker C, Hopster K, Rohn K, Kästner SB.In the horse, effects of cardiovascular-active drugs on local perfusion of the gastrointestinal tract are poorly understood. Objective: To determine the effect of drugs commonly used to support blood pressure, on local intestinal blood flow and tissue oxygenation under isoflurane anaesthesia. Methods: In vivo randomised crossover experiment. Methods: Ten horses were anaesthetised with isoflurane. After 90 min of equilibration three doses (μg/kg bwt/min) of dobutamine (DOB 0.5/1/3), dopamine (DA 1/2/5), noradrenaline (NA 0.1/0.2/0.5) and phenylephrine (PHE 0.5/1/3) were infused for 15 min, in ...
Therapeutics for Equine Endocrine Disorders.
The Veterinary clinics of North America. Equine practice    February 9, 2017   Volume 33, Issue 1 127-139 doi: 10.1016/j.cveq.2016.11.003
Durham AE.Equine endocrine disease is commonly encountered by equine practitioners. Pituitary pars intermedia dysfunction (PPID) and equine metabolic syndrome (EMS) predominate. The most logical therapeutic approach in PPID uses dopamine agonists; pergolide mesylate is the most common. Bromocryptine and cabergoline are alternative drugs with similar actions. Drugs from other classes have a poor evidence basis, although cyproheptadine and trilostane might be considered. EMS requires management changes as the primary approach; reasonable justification for use of drugs such as levothyroxine and metformin m...
Longitudinal changes in serum catecholamines, dopamine, serotonin, ACTH and cortisol in pregnant Spanish mares.
Research in veterinary science    January 21, 2017   Volume 115 29-33 doi: 10.1016/j.rvsc.2017.01.020
Marcilla M, Muñoz A, Satué K.Systemic physiological changes required for placental and fetal development during pregnancy are associated with an activation of the sympathetic nervous system (SNS) and the hypothalamus-pituitary-adrenal axis (HPA) in women, but this fact has not been investigated in mares. Venous blood samples were taken monthly from 31 successful Spanish mares during the 11months of pregnancy. During the first 4months of pregnancy, adrenaline (AD), dopamine (DOPA) and ACTH increases, whereas 5-hydroxitryptamine (5-HT) decreased, and noradrenaline (NAD) and cortisol (CORT) did not change. Serum NAD increase...
Neural modulators of temperament: A multivariate approach to personality trait identification in the horse.
Physiology & behavior    September 3, 2016   Volume 167 125-131 doi: 10.1016/j.physbeh.2016.08.029
Roberts K, Hemmings AJ, Moore-Colyer M, Parker MO, McBride SD.A relationship between dopamine and temperament has previously been described in human cases of dopaminergic dysfunction. Adjustment in temperament prior to disease manifestation can enable the early identification of individuals at risk of such conditions, and scope exists to extend this application of temperament alterations to cases of dopaminergic dysfunction in horses. A multivariate and mixed-methods approach utilising a questionnaire along with two inferred measurements of dopamine activity (Spontaneous Blink Rate [SBR] and behavioral initiation rate [BIR]) were recorded from direct obs...
The effect of isosorbide dinitrate on uterine and ovarian blood flow in cycling and early pregnant mares: A pilot study.
Theriogenology    January 14, 2016   Volume 85, Issue 9 1562-1567 doi: 10.1016/j.theriogenology.2016.01.009
Zoller D, Lüttgenau J, Steffen S, Bollwein H.Poor uterine perfusion has been proposed as a cause of infertility in mares. The objective of this study was to investigate the effect of isosorbide dinitrate (ISDN), a nitric oxide donor, on uterine and ovarian blood flow resistance during diestrus and early pregnancy in mares. Six Trotter mares, aged 7 to 14 years, were examined daily during the first 11 days of three diestrous periods, and five of those mares were also examined during the first 11 days of two pregnancies. Six mares randomly received a placebo, a low dose (30 mg, ISDN30), or a high dose of ISDN (60 mg, ISDN60) through t...
Proteomic Profiling of Cranial (Superior) Cervical Ganglia Reveals Beta-Amyloid and Ubiquitin Proteasome System Perturbations in an Equine Multiple System Neuropathy.
Molecular & cellular proteomics : MCP    September 13, 2015   Volume 14, Issue 11 3072-3086 doi: 10.1074/mcp.M115.054635
McGorum BC, Pirie RS, Eaton SL, Keen JA, Cumyn EM, Arnott DM, Chen W, Lamont DJ, Graham LC, Llavero Hurtado M, Pemberton A, Wishart TM.Equine grass sickness (EGS) is an acute, predominantly fatal, multiple system neuropathy of grazing horses with reported incidence rates of ∼2%. An apparently identical disease occurs in multiple species, including but not limited to cats, dogs, and rabbits. Although the precise etiology remains unclear, ultrastructural findings have suggested that the primary lesion lies in the glycoprotein biosynthetic pathway of specific neuronal populations. The goal of this study was therefore to identify the molecular processes underpinning neurodegeneration in EGS. Here, we use a bottom-up approach be...
Equine pituitary pars intermedia dysfunction: current perspectives on diagnosis and management.
Veterinary medicine (Auckland, N.Z.)    August 20, 2015   Volume 6 293-300 doi: 10.2147/VMRR.S74191
Spelta CW.Equine pituitary pars intermedia dysfunction (PPID) is a neurodegenerative disease of the hypothalamus, resulting in the loss of dopaminergic inhibition of pars intermedia. An oxidative stress injury of unknown etiology has been suggested to initiate the neurodegeneration. While hypertrichosis (formerly known as hirsutism) is considered pathognomic for advanced disease, the antemortem diagnosis of subclinical and early disease has continued to prove difficult. Numerous tests have been used with varying sensitivities and specificities. The overnight dexamethasone suppression test, originally do...
Presence and function of dopamine transporter (DAT) in stallion sperm: dopamine modulates sperm motility and acrosomal integrity.
PloS one    November 17, 2014   Volume 9, Issue 11 e112834 doi: 10.1371/journal.pone.0112834
Urra JA, Villaroel-Espíndola F, Covarrubias AA, Rodríguez-Gil JE, Ramírez-Reveco A, Concha II.Dopamine is a catecholamine with multiple physiological functions, playing a key role in nervous system; however its participation in reproductive processes and sperm physiology is controversial. High dopamine concentrations have been reported in different portions of the feminine and masculine reproductive tract, although the role fulfilled by this catecholamine in reproductive physiology is as yet unknown. We have previously shown that dopamine type 2 receptor is functional in boar sperm, suggesting that dopamine acts as a physiological modulator of sperm viability, capacitation and motility...
The analysis of pergolide residues in horse plasma by LC with fluorescence detection.
Journal of AOAC International    March 22, 2014   Volume 96, Issue 6 1487-1493 doi: 10.5740/jaoacint.12-282
Doran G, Hughes K, Rendle D, Edwards S.Pergolide is used to treat pituitary pars intermedia dysfunction (equine Cushing's Disease), a neurodegenerative condition associated with loss of dopaminergic inhibition of the pituitary in horses. After oral administration, only low concentrations of the drug are achieved in plasma, making drug detection and quantification difficult. While direct analysis of plasma using sensitive MS/MS techniques is possible, dirty plasma samples and mobile phase buffers can cause instrumentation to become rapidly incapacitated. A method using LC with fluorescence detection was developed for pergolide analy...
Determination of pergolide in horse plasma by UPLC-MS/MS for pharmacokinetic applications.
Journal of pharmaceutical and biomedical analysis    January 24, 2014   Volume 94 54-57 doi: 10.1016/j.jpba.2014.01.016
Jacobson GA, Pirie A, Edwards S, Hughes KJ, Rendle DI, Davies NW.Pergolide, an ergot-derived dopamine D2 receptor agonist, is used extensively as an orally administered treatment for pituitary pars intermedia dysfunction (PPID) in horses. One of the barriers associated with pergolide determinations in plasma for pharmacokinetic applications has been the technically demanding requirement for sensitivity. The objective of our work was to develop a simple assay for the determination of pergolide in plasma and demonstrate its potential application in the study of pergolide pharmacokinetics (PK) in horses. A UPLC-MS/MS assay was developed with a simple sample pr...
1 2 3 5